Stefan Roberts
Principal investigator, leads INSOMA BIO, INC..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$8.6MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $8.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 16, 2024 | NIH | SBIR Phase I An off the shelf alternative to fat transfer for soft tissue repair | $294K | INSOMA BIO, INC. |
| Aug 1, 2024 | NIH | STTR Phase I Enhancing Peripheral Nerve Repair with an Injectable Recombinant Polypeptide Scaffold | $296K | INSOMA BIO, INC. |
| Sep 1, 2023 | NSF | SBIR Phase II SBIR Phase II:An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts | $1.7M | INSOMA BIO, INC. |
| Aug 23, 2023 | NSF | SBIR Phase II SBIR Phase II: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts | $1.7M | INSOMA BIO, INC. |
| May 22, 2023 | NIH | SBIR Phase II A recombinant matrix to improve autologous tissue grafts | $1.0M | INSOMA BIO, INC. |
| Apr 1, 2023 | NIH | SBIR Phase I Arecombinant elastin skin substitute for the treatment of burns | $282K | INSOMA BIO, INC. |
| Mar 31, 2023 | NIH | SBIR Phase I A recombinant elastin skin substitute for the treatment of burns | $282K | INSOMA BIO, INC. |
| Jul 1, 2022 | NIH | SBIR Phase II A recombinant matrix to improve autologous tissue grafts | $2.0M | INSOMA BIO, INC. |
| Sep 21, 2021 | NIH | SBIR Phase I Fully defined matrices for organoid culture | $291K | INSOMA BIO, INC. |
| Jul 15, 2021 | NSF | SBIR Phase I SBIR Phase I: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts | $253K | INSOMA BIO, INC. |
| Jul 6, 2021 | NSF | SBIR Phase I SBIR Phase I: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts | $253K | INSOMA BIO, INC. |
| Sep 11, 2019 | NIH | STTR Phase I A recombinant matrix to improve autologous tissue grafts | $255K | INSOMA BIO, INC. with DUKE UNIVERSITY |
1 patents as inventor
- US INSOMA BIO, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#100
Awards as PI#97
Patents#505
Companies
- INSOMA BIO, INC.Leads (SEC Form D) · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.